561
[Vendor] WXT order #13 — Germany, 19 days, no drama, receipts inside
Trying to settle this properly because the thread from last year went in circles. The claim: private plan matters. The counter-claim: it is measurement error. Both…
u/draw_up_dizzy
Air bubble anxiety in an insulin syringe is not proportional to the risk.
newer member · joined 31 Mar 2025
3,633post karma
4,821comment karma
3submissions
93comments
Overview — page 3 of 5
comment on [Vendor] WXT order #13 — Germany, 19 days, no drama, receipts inside in c/glp1canada · 33 points · 7 months ago
Week 82 for me and the honest summary is: 13kg down, muscle cramps manageable, and I have thought about food maybe four times today.
comment on [Vendor] WXT order #13 — Germany, 19 days, no drama, receipts inside in c/glp1canada · 11 points · 7 months ago
Yeah, Spain coverage is not Spain coverage.
comment on three years of telehealth threads, summarised so you do not have to read them in c/compounding · 10 points · 7 months ago
the shortage list is temporary, it ends and compounding becomes illegal again
comment on survodutide vs glucagon — genuinely asking which matters more in c/survodutide · 28 points · 8 months ago
do not generalise from tirzepatide
comment on survodutide vs glucagon — genuinely asking which matters more in c/survodutide · 7 points · 8 months ago
the safety profile is not just tirzepatide amplified
comment on survodutide vs glucagon — genuinely asking which matters more in c/survodutide · 11 points · 8 months ago
Which trial arm?
comment on [Results] 81 weeks on 12.5mg, full numbers, ask me anything boring in c/trialwatch · 82 points · 8 months ago
off-label use data is different from approved-indication data
comment on [Results] 81 weeks on 12.5mg, full numbers, ask me anything boring in c/trialwatch · 282 points · 9 months ago
I am going to push back on this slightly.
comment on FLOW vs TRIUMPH — genuinely asking which matters more in c/trialwatch · 1 points · 9 months ago
number-needed-to-treat is the house dialect
comment on is it normal to get injection-site soreness at week 54 in c/glp1canada · 23 points · 9 months ago
My version of this: I was so worried about the injection that I put it off for eleven days.
Adding to this: special authorization is doing more work than the comment implies.
comment on does regain actually matter or is it forum lore at this point in c/maintenancephase · 80 points · 10 months ago
no
comment on [Vendor] QST order #8 — Canada, 9 days, no drama, receipts inside in c/survodutide · 1 points · 10 months ago
phase 15 data is interesting, phase 3 will be different
comment on 503B vs shortage list — genuinely asking which matters more in c/compounding · 1 points · 10 months ago
state board rules differ, say which state
comment on [Discussion] we are measuring MASH at the wrong time and calling it noise in c/survodutide · 14 points · 11 months ago
do not generalise from tirzepatide
comment on reading STEP threads from 2024 and half of it aged badly in c/trialwatch · 9 points · 11 months ago
This is correct. Discontinuation arms show the regain reality.
comment on [Results] 61 weeks on 1.7mg, full numbers, ask me anything boring in c/compounding · 16 points · 11 months ago
API transparency is the question that separates good compounders from sketchy ones
comment on anyone else notice dual agonist kicking in around week 80 in c/survodutide · 1 points · 11 months ago
glucagon co-agonism has a different safety story
comment on help me understand endpoint, I have read the wiki twice in c/trialwatch · 4 points · 12 months ago
the relative risk reduction in headlines is not the whole story
comment on help me understand endpoint, I have read the wiki twice in c/trialwatch · 13 points · 12 months ago
phase 2 is not phase 3, smaller n and shorter trial
Disagree on that part. 95.1% and 98.9% on the same vial is normal.